Halozyme provides update on German preliminary injunction hearing
MRK•Halozyme disagrees with a German court overturning an injunction that halted the launch of Keytruda SC in Germany and plans to file an infringement lawsuit against Merck seeking permanent relief.
1. Planned lawsuit
Halozyme Therapeutics said it disagrees with the German court overturning the injunction and will file an infringement lawsuit against Merck in Germany, seeking permanent relief.
Related News

Abbott starts VOYAGER CE trial of Encantor heart valve system for aortic stenosis
ABT•

BofA Global Research initiates coverage of Viridian Therapeutics with buy rating; price objective $47
VRDN•


